Overall rank by patents
#21,069
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 2 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Embolx ranks #21,069 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R21069 · US Corporation #21,069 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Electronic Warfare Associates, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Embolx · this assignee
25 score
3D Lighting Innovati… · lowest
7 score
What this shows Embolx's Innovation Score is 25.4/100 (top 83% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Embolx, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2018. By volume, Embolx sits between Electronic Warfare Associates, Inc. and Emery Allen, Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Electronic Warfare Associates, Inc.
13 patents
Elira, Inc.
13 patents
Eliza LLC
13 patents
Emblation Limited
13 patents
Emerson Automation Solutions Final Control US LP
13 patents
Emerson Network Power, Energy Systems, North America, Inc.
13 patents
Emerson Process Management Valve Automation, Inc.
13 patents
Emery Allen, LLC
13 patents
Embolx, Inc.
13 patents
What this shows Embolx holds 13 patents at rank #21,086, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #21,086 in granted patent volume.
Other assignees with the most granted patents in Embolx's primary technology class.
Embolx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 Top 83% higher than 17% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 15.4% |
| 2017 | 2 | 15.4% |
| 2018 | 1 | 7.7% |
| 2019 | 1 | 7.7% |
| 2020 | 3 | 23.1% |
| 2021 | 1 | 7.7% |
| 2022 | 1 | 7.7% |
| 2025partial year | 2 | 15.4% |
Top 2 of 2 technology areas
Overall rank by patents
#21,069
of 50,000 tracked assignees
25.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.